Zimmer Biomet Holdings Stock Price To Earning
| ZIM Stock | EUR 101.45 0.10 0.1% |
Zimmer Biomet Holdings fundamentals help investors to digest information that contributes to Zimmer Biomet's financial success or failures. It also enables traders to predict the movement of Zimmer Stock. The fundamental analysis module provides a way to measure Zimmer Biomet's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Zimmer Biomet stock.
Zimmer |
Zimmer Biomet Holdings Company Price To Earning Analysis
Zimmer Biomet's Price to Earnings ratio is typically used for current valuation of a company and is one of the most popular ratios that investors monitor daily. Holding a low PE stock is less risky because when a company's profitability falls, it is likely that earnings will also go down as well. In other words, if you start from a lower position, your downside risk is limited. There are also some investors who believe that low Price to Earnings ratio reflects the low pricing because a given company is in trouble. On the other hand, a higher PE ratio means that investors are paying more for each unit of profit.
Current Zimmer Biomet Price To Earning | 10.60 X |
Most of Zimmer Biomet's fundamental indicators, such as Price To Earning, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Zimmer Biomet Holdings is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Generally speaking, the Price to Earnings ratio gives investors an idea of what the market is willing to pay for the company's current earnings.
| Competition |
Based on the latest financial disclosure, Zimmer Biomet Holdings has a Price To Earning of 10.6 times. This is 58.98% lower than that of the Healthcare sector and 84.83% lower than that of the Medical Devices industry. The price to earning for all Germany stocks is 63.09% higher than that of the company.
Zimmer Price To Earning Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Zimmer Biomet's direct or indirect competition against its Price To Earning to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Zimmer Biomet could also be used in its relative valuation, which is a method of valuing Zimmer Biomet by comparing valuation metrics of similar companies.Zimmer Biomet is currently under evaluation in price to earning category among its peers.
Zimmer Fundamentals
| Return On Equity | 0.0236 | |||
| Return On Asset | 0.0371 | |||
| Profit Margin | 0.03 % | |||
| Operating Margin | 0.19 % | |||
| Current Valuation | 29.79 B | |||
| Shares Outstanding | 210.06 M | |||
| Shares Owned By Institutions | 90.95 % | |||
| Price To Earning | 10.60 X | |||
| Price To Book | 2.15 X | |||
| Price To Sales | 3.27 X | |||
| Revenue | 6.94 B | |||
| Gross Profit | 4.92 B | |||
| EBITDA | 1.49 B | |||
| Net Income | 231.4 M | |||
| Cash And Equivalents | 403.1 M | |||
| Cash Per Share | 1.97 X | |||
| Total Debt | 5.32 B | |||
| Debt To Equity | 74.70 % | |||
| Current Ratio | 1.19 X | |||
| Book Value Per Share | 57.51 X | |||
| Cash Flow From Operations | 1.28 B | |||
| Earnings Per Share | 1.30 X | |||
| Price To Earnings To Growth | 1.06 X | |||
| Target Price | 188.04 | |||
| Number Of Employees | 18 K | |||
| Beta | 1.02 | |||
| Market Capitalization | 24.63 B | |||
| Total Asset | 21.07 B | |||
| Z Score | 2.4 | |||
| Annual Yield | 0.01 % | |||
| Five Year Return | 0.72 % | |||
| Net Asset | 21.07 B | |||
| Last Dividend Paid | 0.96 |
About Zimmer Biomet Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Zimmer Biomet Holdings's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Zimmer Biomet using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Zimmer Biomet Holdings based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Additional Information and Resources on Investing in Zimmer Stock
When determining whether Zimmer Biomet Holdings offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Zimmer Biomet's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Zimmer Biomet Holdings Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Zimmer Biomet Holdings Stock:Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Zimmer Biomet Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.